KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
KIORA PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.38−0.02 (-0.83%)
Close on Oct 19, 2026
- Market cap
- $14.70M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Kiora Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2026 | Aug 19, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 16, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 3, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | Jun 3, 2025 | SEC EDGAR |
| Current report | 8-K | May 9, 2025 | May 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 16, 2025 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 15, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 8, 2024 | Nov 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 29, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 9, 2024 | Aug 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2024 | Jul 30, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 28, 2024 | Jul 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 10, 2024 | May 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 3, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 1, 2024 | Mar 25, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2024 | Mar 25, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 25, 2024 | SEC EDGAR |